476 related articles for article (PubMed ID: 31396720)
1. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
Moonen M; Oury C; Lancellotti P
Curr Oncol Rep; 2017 Aug; 19(10):63. PubMed ID: 28791609
[TBL] [Abstract][Full Text] [Related]
3. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
4. Advanced imaging modalities to detect cardiotoxicity.
Awadalla M; Hassan MZO; Alvi RM; Neilan TG
Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
[TBL] [Abstract][Full Text] [Related]
5. Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives.
Kersting D; Mavroeidi IA; Settelmeier S; Seifert R; Schuler M; Herrmann K; Rassaf T; Rischpler C
J Nucl Med; 2023 Nov; 64(Suppl 2):29S-38S. PubMed ID: 37918843
[TBL] [Abstract][Full Text] [Related]
6. The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment.
Wengrofsky P; Feldman S
Curr Cardiol Rep; 2023 Jan; 25(1):1-8. PubMed ID: 36527535
[TBL] [Abstract][Full Text] [Related]
7. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
Garg V; Vorobiof G
Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
[TBL] [Abstract][Full Text] [Related]
8. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient.
Plana JC; Thavendiranathan P; Bucciarelli-Ducci C; Lancellotti P
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1173-1186. PubMed ID: 30092972
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity due to chemotherapy: role of cardiac imaging.
Poulin F; Thavendiranathan P
Curr Cardiol Rep; 2015 Mar; 17(3):564. PubMed ID: 25648628
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of Biological Therapies in Cancer Patients: An In-depth Review.
Madanat L; Gupta R; Weber P; Kumar N; Chandra R; Ahaneku H; Bansal Y; Anderson J; Bilolikar A; Jaiyesimi I
Curr Cardiol Rev; 2023; 19(3):e310522205428. PubMed ID: 35642110
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced myocardial dysfunction - recommendations for assessment in clinical and pre-clinical studies.
Ebrahimi A; Raichlen JS; Pointon A; Gottfridsson C; Munley J; Hockings P; Cartwright J; Buss N; Wikström J; Gan LM; Whittaker A; Khalil A; George RT; Garkaviy P; Brott D
Expert Opin Drug Saf; 2020 Mar; 19(3):281-294. PubMed ID: 32064957
[No Abstract] [Full Text] [Related]
12. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
[TBL] [Abstract][Full Text] [Related]
14. Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
Merino T; Pinto MP; Orellana MP; Martinez G; Andía M; Munoz-Schuffenegger P; Acevedo F; Gabrielli L; Sanchez C; Pereira J
BMC Cancer; 2021 Oct; 21(1):1114. PubMed ID: 34663256
[TBL] [Abstract][Full Text] [Related]
15. Update in imaging of cancer therapy-related cardiac toxicity in adults.
de Baat EC; Naaktgeboren WR; Leiner T; Teske AJ; Habets J; Grotenhuis HB
Open Heart; 2021 Apr; 8(1):. PubMed ID: 33863836
[TBL] [Abstract][Full Text] [Related]
16. Identifying cancer patients at risk for cardiotoxicity.
Salvatici M; Sandri MT
Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
[TBL] [Abstract][Full Text] [Related]
17. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity in oncology and coronary microcirculation: future challenges in theranostics.
Peretto G; Lazzeroni D; Sartorio CL; Camici PG
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1760-1773. PubMed ID: 28410144
[TBL] [Abstract][Full Text] [Related]
19. Cardio-oncology: the role of advanced echocardiography in cancer patients.
Venneri L; Zoppellaro G; Khattar RS
Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
[TBL] [Abstract][Full Text] [Related]
20. Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients.
Schiffer W; Pedersen LN; Lui M; Bergom C; Mitchell JD
Curr Cardiol Rep; 2023 Nov; 25(11):1589-1600. PubMed ID: 37796395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]